Updated:
ICU Medical
ICU Medical is the world's leading pure-play infusion therapy company, committed to delivering quality, innovation, and value to customers worldwide.
ICU Medical
ICU Medical is the world's leading pure-play infusion therapy company, committed to delivering quality, innovation, and value to customers worldwide. The company designs technology to support clinicians and human connection in healthcare, with products spanning infusion therapy, pharmacy preparation, airway management, hemodynamic monitoring, temperature management, renal care, and pain management. Its purpose is to support a healthcare experience free from preventable harm, and its mission is to empower clinicians to drive measurable improvements in every patient's care.
General information
Firm type
Asset Manager
Year founded
1984
Location
Region
North America
Country
United States
City
San Clemente
Corporate office
San Clemente, CA, United States
Principals
Vivek Jain
Chairman and CEO
Brian Bonney
Chief Financial Officer
C. Scott Lamb
Chief Commercial Officer
Sector focus
Frequently asked questions
Who runs investment decisions at ICU Medical?
Vivek Jain serves as Chairman and CEO, overseeing corporate strategy and capital allocation. CFO Brian Bonney and the executive team manage balance sheet decisions. The company is publicly traded, so strategic investments — including M&A and R&D spending — are approved by the board and disclosed in quarterly filings (per the firm's official communications).
What investment stages does ICU Medical typically target?
ICU Medical's investment focus is internal: R&D for new infusion systems, disposables, and connectivity software. The firm occasionally acquires complementary technologies or manufacturing capabilities, such as the 2017 Hospira infusion systems acquisition. It does not invest in startups or external funds as a core activity.
How does ICU Medical source proprietary deal flow?
As a public company, ICU Medical evaluates potential acquisitions through industry partnerships, hospital feedback, and regulatory trends. Deal flow comes from hospital supply chain relationships, FDA clearance processes, and competitive landscape analysis. The firm does not operate a separate investment sourcing team.
Which sectors does ICU Medical explicitly avoid?
ICU Medical focuses exclusively on infusion therapy and hospital-connected care technologies. It explicitly avoids primary care devices, diagnostic imaging, pharmaceuticals, and consumer health products. The firm's specificity is a strategic choice — it concentrates resources on one clinical workflow across every hospital market.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: